Ki16425 (Compound)

Pubchem:PUBCHEM:10367662

Id:19ce60ed-15cb-56c6-b5fd-2f57230fb283

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Ki16425's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Ki16425.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Ki16425.

Results found

Linked to

	Label	Description
	Ki16425 positively regulates CEACAM6 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Ki16425 positively regulates LAMP5 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Ki16425 bioactivity Lysophosphatidic acid receptor 3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Ki16425 negatively regulates CXCL13 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Ki16425 in similarity relationship with 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Ki16425 negatively regulates MT1H Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Ki16425 positively regulates SKAP2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Ki16425 positively regulates FABP4 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Ki16425 positively regulates IRS1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Ki16425 positively regulates PEG3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS